Viewing nowNexpra Tablet 20 Milligrams (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 201404801 · Approved 2014.10.20 · Insurance code 657805450
Treatment of gastroesophageal reflux disease, gastrointestinal disorders (e.g., ulcers), and Zollinger-Ellison syndrome
This medication is used for maintenance therapy for the treatment of gastroesophageal reflux disease and erosive reflux esophagitis to prevent recurrence. It is also effective in treating and preventing recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It helps treat upper gastrointestinal symptoms related to the use of non-steroidal anti-inflammatory drugs and also aids in the treatment and prevention of gastric and duodenal ulcers that may occur with long-term use of this medication. It is also used for maintenance therapy to prevent rebleeding after intravenous administration in Zollinger-Ellison syndrome. It is effectively used for the treatment and prevention of various gastrointestinal diseases.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent recurrent symptoms are controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, as-needed administration is not recommended to control recurring symptoms. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg, twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors): 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials longer than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Older adults: No dose adjustment is necessary.
Adolescents aged 12 years or older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents aged 12 years or older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years or older — Once symptoms have resolved, subsequent recurrent symptoms are controlled by administering 20 mg once daily. Adolescents aged 12 years or older — In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, as-needed administration is not recommended to control recurring symptoms. Children under 12 years of age: There is no experience with administering this medicine to children under 12 years of age.
This medication should not be administered to certain patients. For example, patients with known allergies to this medication or its components, a history of hypersensitivity, those allergic to penicillin or macrolide antibiotics, patients taking certain heart-related medications, nursing women, or patients with a history of myocardial infarction should not use this medication. Additionally, caution should be exercised when administering this medication to patients allergic to Yellow 5 dye. There may be various adverse reactions when using this medication, so caution is needed. Commonly reported symptoms include headaches, abdominal pain, diarrhea, and constipation, while rare side effects may include blood abnormalities, allergic reactions, hypomagnesemia, psychiatric symptoms, liver dysfunction, skin rashes, and severe skin reactions. Prolonged use of this medication may mask symptoms of malignant tumors; therefore, diagnostic evaluations by a doctor and regular examinations are required. Furthermore, there may be an increased risk of fractures with long-term use, so patients at risk of osteoporosis should exercise caution. This medication may interact with other drugs, so it is essential to consult a doctor or pharmacist when used in conjunction with antibiotics, antiviral agents, anticoagulants, anticonvulsants, etc. During pregnancy, no specific harm was found in animal studies, but caution should be exercised when administering it to pregnant women, and nursing women should avoid using this medication. In case of overdose, there is no specific antidote, and treatment should be symptomatic; this medication is not removed by dialysis, necessitating caution. Lastly, it is important to keep this medication out of reach of children and not to transfer it to other containers to maintain quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, confusion, depression, aggression, hallucination, headache, dizziness, dysesthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distention, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, hyperhidrosis, Clostridium difficile-associated diarrhea, abdominal distention, allergic reactions, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated plasma gastrin, lingual disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, worsening of depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vulvovaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric adenomatous polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 and 30 degrees Celsius. This will help maintain the drug's effectiveness over time.
Pale pink round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.